Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Silva3, Kate Barry2, Ali Fathi4, Simin Maleknia4, Paul Young1,3,5, Daniela Traini1,2, Hui Xin Ong1,2,3 1Respiratory Technology, The Woolcock Institute of Medical Research, Sydney, NSW 2037, Australia 2Macquarie Medical School, Faculty of Medicine, Health, and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia 3Ab Initio Pharma Pty Ltd, Sydney, NSW, Australia 4Tetratherix Technology Pty Ltd, Sydney, NSW, Australia 5Department of Marketing, Business School, Macquarie University, Sydney, NSW 2109, Australia Summary: In this study, a novel synthetic thermosensitive polymer, poly(Nisopropylacrylamide)co(polylactide/2hydroxy methacrylate)co(oligo (ethylene glycol), denoted as TP, is presented as a promising drug carrier for sustained intranasal drug delivery
DESCONTOS NOS EVENTOS ANA-APD INSCRIES PRIVILEGIADAS Aos scios ANA, acresce a vantagem de descontos nas inscries de todos os nossos eventos
The companys lead candidate (NPI-001), manufactured using a patented process, is the amide form of N-acetyl-L-cysteine (NAC)
Inhibition of CCL28/CCR10-Mediated eNOS downregulation improves skin wound healing in the obesity-induced mouse Model of Type 2 Diabetes
US$ 24.44
US$ 28.32
US$ 26.04
US$ 23.92
